Episode 9

The Age of the Oncodermatologist: Championing Preventative Side-Effect Management

Dr Nicole LeBoeuf, Dr Beth McLellan, and Dr Ian Tattersall, have all chosen to specialise in the skin toxicity side effects of patient’s undergoing cancer treatment. In a discussion led by Dr Corina van den Hurk, they talk about being embedded within their respective oncology units, the side effects they witness daily affecting the skin, hair, and nails of patients receiving chemotherapy and radiation therapy, and the lasting impact this can have on quality of life.

With patients often referred to their services once treatment has finished, they explain why dermatological interventions can be significantly more effective if they are positioned as a preventative measure in the treatment timeline, as opposed to a curative measure at the end.

Key topics discussed:

05:40 - The panel introduce Oncodermatology and how many patients experience dermatological toxicities

09:07 - Dr Beth McLellan explains how patients can choose chemotherapies based on the side-effects

11:29 - Dr Nicole LeBoeuf discusses how hair retention is more than vanity, but can give patients a sense of privacy and normalcy

13:50 - What role can an Oncodermatologist play in preventing these side-effects?

14:47 - Why Oncodermatology needs to be preventative, rather than curative

16:28 - Teledermatology

19:00 - Oncodermatology as an emerging field

26:37 - Grading adverse events in Dermatology

31:01 - The Oncodermatology role in scalp cooling

31:59 - Where do the panel see Oncodermatology in 10 years time?

 

Guests

Dr Corina van den Hurk, Dr Nicole LeBoeuf, Dr Beth McLellan, and Dr Ian Tattersall

Clinical Studies Discussed

  • Lacouture ME, et al. Prevention and management of dermatological toxicities related to anticancer agents: ESMO Clinical Practice Guidelines. Ann Oncol. 2021 Feb;32(2):157-170.
  • Lacouture ME, et al. Clinical practice guidelines for the prevention and treatment of EGFR inhibitor-associated dermatologic toxicities. Support Care Cancer. 2011 Aug;19(8):1079-95.
Download full transcript
Episode 9
The Age of the Oncodermatologist: Championing Preventative Side-Effect Management

Dr Nicole LeBoeuf, Dr Beth McLellan, and Dr Ian Tattersall, have all chosen to specialise in the skin toxicity side effects of patient’s undergoing cancer treatment. In a discussion led by Dr Corina van den Hurk, they talk about being embedded within their respective oncology units, the side effects they witness daily affecting the skin, hair, and nails of patients receiving chemotherapy and radiation therapy, and the lasting impact this can have on quality of life.

With patients often referred to their services once treatment has finished, they explain why dermatological interventions can be significantly more effective if they are positioned as a preventative measure in the treatment timeline, as opposed to a curative measure at the end.

Scroll to listen
More Episodes
Episode 11
Why Equity Matters in Cancer Care
Listen Now -->
Episode 10
Back to Basics: Why Protocols are the KEY to Efficacious Side-Effect Management
Listen Now -->

About this Episode

Dr Nicole LeBoeuf, Dr Beth McLellan, and Dr Ian Tattersall, have all chosen to specialise in the skin toxicity side effects of patient’s undergoing cancer treatment. In a discussion led by Dr Corina van den Hurk, they talk about being embedded within their respective oncology units, the side effects they witness daily affecting the skin, hair, and nails of patients receiving chemotherapy and radiation therapy, and the lasting impact this can have on quality of life.

With patients often referred to their services once treatment has finished, they explain why dermatological interventions can be significantly more effective if they are positioned as a preventative measure in the treatment timeline, as opposed to a curative measure at the end.

Key Topics Discussed

05:40 - The panel introduce Oncodermatology and how many patients experience dermatological toxicities

09:07 - Dr Beth McLellan explains how patients can choose chemotherapies based on the side-effects

11:29 - Dr Nicole LeBoeuf discusses how hair retention is more than vanity, but can give patients a sense of privacy and normalcy

13:50 - What role can an Oncodermatologist play in preventing these side-effects?

14:47 - Why Oncodermatology needs to be preventative, rather than curative

16:28 - Teledermatology

19:00 - Oncodermatology as an emerging field

26:37 - Grading adverse events in Dermatology

31:01 - The Oncodermatology role in scalp cooling

31:59 - Where do the panel see Oncodermatology in 10 years time?

 

Guests

Dr Corina van den Hurk, Dr Nicole LeBoeuf, Dr Beth McLellan, and Dr Ian Tattersall

Shownotes

  • Lacouture ME, et al. Prevention and management of dermatological toxicities related to anticancer agents: ESMO Clinical Practice Guidelines. Ann Oncol. 2021 Feb;32(2):157-170.
  • Lacouture ME, et al. Clinical practice guidelines for the prevention and treatment of EGFR inhibitor-associated dermatologic toxicities. Support Care Cancer. 2011 Aug;19(8):1079-95.

Transcript

With the biggest names in oncology
Now streaming on all platforms
© Paxman Coolers 2022